ResearcherKagoshima UniversityActive in the last 2 years
Makoto Hinokuchi
Matched on ORCID iD 0000-0002-5805-9502; OpenAlex author ID A5019523753. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Disease and Pancreatic Cancer: A Case-Contro… Co-author DOI 10.3390/jcm15197543↗
- Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospective multicenter exploratory study. Co-author DOI 10.1002/jhbp.1239↗
- Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. Co-author DOI 10.2169/internalmedicine.0224-22↗
- Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prosp… Co-author DOI 10.3390/diagnostics13061078↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiho Arima · 4 shared papers, 2023–2026 · strength 0.75
- Paper Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Dise… DOI 10.3390/jcm15197543↗
- Paper Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospec… DOI 10.1002/jhbp.1239↗
- Paper Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. DOI 10.2169/internalmedicine.0224-22↗
- Shinichi Hashimoto · 4 shared papers, 2023–2026 · strength 0.75
- Paper Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Dise… DOI 10.3390/jcm15197543↗
- Paper Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospec… DOI 10.1002/jhbp.1239↗
- Paper Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. DOI 10.2169/internalmedicine.0224-22↗
- Takao Ohtsuka · 3 shared papers, 2023–2026 · strength 0.57
- Paper Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Dise… DOI 10.3390/jcm15197543↗
- Paper Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospec… DOI 10.1002/jhbp.1239↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Akio Ido · 3 shared papers, 2023 · strength 0.51
- Paper Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospec… DOI 10.1002/jhbp.1239↗
- Paper Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. DOI 10.2169/internalmedicine.0224-22↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Michiyo Higashi · 2 shared papers, 2023 · strength 0.33
- Paper Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. DOI 10.2169/internalmedicine.0224-22↗
- Paper Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultra… DOI 10.3390/diagnostics13061078↗
- Tetsuya Idichi · 1 shared paper, 2026 · strength 0.24
- Yuko Mataki · 1 shared paper, 2026 · strength 0.24
- Yusuke Kamikihara · 1 shared paper, 2026 · strength 0.24
- Nobuhisa Maeda · 1 shared paper, 2023 · strength 0.18
- Akihide Tanimoto · 1 shared paper, 2023 · strength 0.15
- Hiromichi Iwaya · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.